U.S. Department of Transportation (DOT) Drug & Alcohol Testing Regulations

Overview

The Federal Motor Carrier Safety Administration (FMCSA), a division of the U.S. Department of Transportation, enforces a comprehensive drug and alcohol testing program for commercial motor vehicle (CMV) operators. The regulations are codified in 49CFR382.1382.147 and are designed to improve roadway safety by preventing impaired driving.

Key objectives of the DOT testing program are:

• Deterring drug and alcohol misuse among safetycritical transportation employees.
• Identifying impaired individuals before they operate a CMV.
• Providing a structured process for followup testing and rehabilitation.

Who Is Covered?

The regulations apply to:

• CMV drivers who operate vehicles requiring a commercial drivers license (CDL) and transport hazardous materials in certain quantities.
• Safety-sensitive employees (SSEs) in positions such as:
  • Vehicle maintenance and repair personnel.
  • Dispatchers who direct CMV movements.
  • Hazardous materials (HAZMAT) handlers.
  • Medical personnel responsible for driver fitness examinations.
• Employees of companies that operate under FMCSA authority, regardless of the employers size.

Testing Types

The DOT program requires several categories of testing, each with specific timing and purpose.

1. PreEmployment Testing

All new drivers and safetysensitive employees must undergo a drug test before they are hired or before they begin safetysensitive duties. An alcohol test is not required at this stage.

2. Random Testing

Employers must select a statistically valid random sample of covered employees for drug and alcohol testing each year. The minimum random testing rate is 50% for drug testing and 25% for alcohol testing.

3. PostAccident Testing

After a reportable accident (e.g., a crash resulting in a fatality, a disabling injury, or a vehicle leaving the roadway), the driver must be tested for both drugs and alcohol within 8hours of the accident.

4. Reasonable Suspicion Testing

If an employer or a trained supervisory personnel observes behavior that suggests impairment, they may require the employee to undergo immediate drug and/or alcohol testing.

5. ReturntoDuty and FollowUp Testing

Employees who test positive must complete a substanceabuse professional (SAP) evaluation. After successful rehabilitation, they are subject to a returntoduty test followed by followup testing at 90day, 30day, and 30day intervals.

Testing Procedures

All tests must be performed by a certified collection site and a certified laboratory that meets Department of Health and Human Services (DHHS) guidelines.

Sample Collection

• Urine Primary specimen for drug testing (amphetamines, cocaine, marijuana, opiates, PCP).
• Breath Used for alcohol testing; result reported as bloodalcohol concentration (BAC).

Chain of Custody

Every specimen is documented on a chainofcustody form that records the collector, the employee, the time of collection, and the laboratory receiving the sample. Tampering or loss of custody can invalidate the result.

Result Interpretation

• Drug tests are reported as positive, negative, or refused. A positive result triggers the returntoduty protocol.
• Alcohol results are expressed as a BAC. A BAC of 0.04% or higher is a violation for drivers.

Exceptions & Exemptions

Certain employees are exempt from the testing program, including:

• Employees who do not perform safetysensitive functions and are not required to hold a CDL.
• Drivers whose vehicles are exempt from FMCSA jurisdiction (e.g., farm vehicles used exclusively for agricultural production).
• Parttime drivers who operate a CMV less than 5days per month and do not receive compensation that exceeds the FMCSA threshold.

Recordkeeping Requirements

Employers must retain documentation for a minimum of 5years. Required records include:

• Copies of all test results (both positive and negative).
• Chainofcustody forms and laboratory reports.
• Documentation of any medical review officer (MRO) evaluations.
• Proof of random selection methodology (e.g., computergenerated reports).
• Employee notification and consent forms.

Records must be available for inspection by FMCSA officials upon request.

Penalties for NonCompliance

Violations of DOT testing regulations can result in civil and criminal penalties, including:

• Fines up to $13,653 per violation (adjusted annually for inflation).
• Possible suspension or revocation of operating authority.
• Criminal charges if falsification of test results is proven.

Repeated noncompliance may lead to increased scrutiny, mandatory corrective action plans, and heightened oversight from FMCSA.

Helpful Resources

• FMCSA 382.1 Drug and Alcohol Testing Program Overview
• DOT SubstanceAbuse Policy (OPM)
• SAMHSA Guidelines for Drug Testing
• National Safety Council DOT Drug Testing Checklist